We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Launches Phase 2 Study of Allergic Reactions to Moderna and Pfizer/BioNTech Vaccines
NIH Launches Phase 2 Study of Allergic Reactions to Moderna and Pfizer/BioNTech Vaccines
The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has begun a phase 2 study to evaluate the risk of allergic reactions to the Moderna and Pfizer/BioNTech COVID-19 vaccines in patients who are severely allergic or have a mast-cell disorder.